US2005032123A1PendingUtilityA1
Oncoprotein protein kinase
Est. expiryJul 19, 2013(expired)· nominal 20-yr term from priority
A61K 38/00C12Q 1/485C07K 16/40Y10S435/975C12N 9/12C12Q 1/6897G01N 2333/9121C12N 9/1205G01N 2500/04Y10S435/81
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An isolated polypeptide (JNK) characterized by having a molecular weight of 46kD as determined by reducing SDS-PAGE, having serine and threonine kinase activity, phosphorylating the c-Jun N-terminal activation domain and polynucleotide sequences and method of detection of JNK are provided herein. JNK phosphorylates c-Jun N-terminal activation domain which affects gene expression from AP-1 sites.
Claims
exact text as granted — not AI-modified1 . A method for identifying a compound which affects the activity of INK Protein Kinase characterized by its ability to phosphorylate the c-Jun N-terminal activation domain comprising:
a) incubating the compound and the kinase or a polynucleotide encoding the kinase, wherein the incubation is carried out under conditions sufficient to allow the components to interact; and b) measuring the effect of the compound on the kinase or polynucleotide encoding the kinase.
2 . A method for identifying a compound which affects the activity of a JNK protein kinase characterized by its ability to phosphorylate the c-Jun N-terminal activation domain comprising:
a) administering the compound to T cells expressing the kinase which are cultured under conditions sufficient to allow the components to interact; and b) measuring the effect of the compound on the phosphorylated state of c-Jun.
3 . A method of claim 2 whereby the compound is further assayed for its effect on the activated state of the T cells.
4 . The method of claim 3 whereby the T cells are Jurkat cells.Join the waitlist — get patent alerts
Track US2005032123A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.